PlainRecalls
FDA Drug Low Class III Ongoing

Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79

Reported: November 6, 2019 Initiated: September 23, 2019 #D-0166-2020

Product Description

Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79

Reason for Recall

CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
69696 bottles
Distribution
Nationwide within the United States
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79. Recalled by AuroMedics Pharma LLC. Units affected: 69696 bottles.
Why was this product recalled?
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 6, 2019. Severity: Low. Recall number: D-0166-2020.